Fieldpoint Private Securities’s Boston Scientific BSX Stock Holding History

Fieldpoint Private Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$40K	Sell	1,061 -552	-34%	-$22.5K	0.01%	522
2022 Q1	$71K	Buy	1,613 +50	+3%	+$2.17K	0.01%	497
2021 Q4	$66K	Buy	1,563 +390	+33%	+$16.4K	0.01%	526
2021 Q3	$51K	Sell	1,173 -27	-2%	-$1.2K	0.01%	571
2021 Q2	$51K	Buy	1,200 +650	+118%	+$27.3K	0.01%	566
2021 Q1	$21K	Sell	550 -2,620	-83%	-$99.2K	﹤0.01%	765
2020 Q4	$114K	Buy	+3,170	New	+$114K	0.03%	374
2020 Q1	–	Sell	-1,497	Closed	-$68K	–	288
2019 Q4	$68K	Buy	1,497 +1,071	+251%	+$44.8K	0.02%	376
2019 Q3	$17K	Hold	426	–	–	0.01%	526
2019 Q2	$18K	Buy	+426	New	+$16.4K	0.01%	543

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fieldpoint Private Securities's BSX Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Boston Scientific (BSX) stake by 34% in Q2 2022, selling an estimated $22.5K and leaving 1,061 shares worth $40K. The position accounts for 0.01% of the portfolio, ranked #522.

Fieldpoint Private Securities first reported a position in BSX in Q2 2019 and has held it in 10 quarters since. The position peaked at $114K in Q4 2020. 879 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

Fieldpoint Private Securities held 1,061 shares of Boston Scientific worth $40K as of Q2 2022.
Fieldpoint Private Securities sold 552 Boston Scientific shares in Q2 2022, an estimated $22.5K.
Boston Scientific made up 0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #522 holding.
Fieldpoint Private Securities first reported a position in Boston Scientific in Q2 2019 and has held it in 10 quarters since.
Fieldpoint Private Securities's Boston Scientific position peaked at $114K in Q4 2020.
879 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.